Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP425407.RAmJPN7FfQuWY3pKw3ron6E6zPTI-r-fNwYS7zyv1-FZI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP425407.RAmJPN7FfQuWY3pKw3ron6E6zPTI-r-fNwYS7zyv1-FZI130_assertion type Assertion NP425407.RAmJPN7FfQuWY3pKw3ron6E6zPTI-r-fNwYS7zyv1-FZI130_head.
- NP425407.RAmJPN7FfQuWY3pKw3ron6E6zPTI-r-fNwYS7zyv1-FZI130_assertion description "[The data suggested that the Cx43 and E-cadherin are reduced with NSCLC progression, and might be important biomarkers for judging the metastasis and prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP425407.RAmJPN7FfQuWY3pKw3ron6E6zPTI-r-fNwYS7zyv1-FZI130_provenance.
- NP425407.RAmJPN7FfQuWY3pKw3ron6E6zPTI-r-fNwYS7zyv1-FZI130_assertion evidence source_evidence_literature NP425407.RAmJPN7FfQuWY3pKw3ron6E6zPTI-r-fNwYS7zyv1-FZI130_provenance.
- NP425407.RAmJPN7FfQuWY3pKw3ron6E6zPTI-r-fNwYS7zyv1-FZI130_assertion SIO_000772 23621211 NP425407.RAmJPN7FfQuWY3pKw3ron6E6zPTI-r-fNwYS7zyv1-FZI130_provenance.
- NP425407.RAmJPN7FfQuWY3pKw3ron6E6zPTI-r-fNwYS7zyv1-FZI130_assertion wasDerivedFrom befree-20150227 NP425407.RAmJPN7FfQuWY3pKw3ron6E6zPTI-r-fNwYS7zyv1-FZI130_provenance.
- NP425407.RAmJPN7FfQuWY3pKw3ron6E6zPTI-r-fNwYS7zyv1-FZI130_assertion wasGeneratedBy ECO_0000203 NP425407.RAmJPN7FfQuWY3pKw3ron6E6zPTI-r-fNwYS7zyv1-FZI130_provenance.